Skip to content

Research

Current Studies

Recruitment is Open

CAROLINA Trial
Sam Dagogo-Jack, MD (PI); Helmut Steinberg, MD - Study Coordinator
Sponsor: Boehringer Ingelheim
Type of patients for recruitment: Type 2 diabetes, H/O cardiovascular disease (previous vascular disease or evidence of vascular related end-organ damage), age = 40 and =85 years, high risk of cardiovascular events, with HbA1c 6.5-8.5% (treatment naïve) or 6.5-7.5% (treated)
Contact: Amy Bell, (901) 448-1008; asbell@uthsc.edu

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes (DECLARE)
Samuel Dagogo-Jack, MD (PI); James Ekwensi, MD - Study Coordinator
Participants are Type 2 Diabetes with Cardiovascular Disease
Contact: (901) 448-2676, jekwensi@uthsc.edu

The Effect of Dulaglutide on Major Cardiovascular Events in Patients with Type 2 Diabetes: Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND)
Helmut Steinberg, MD (PI); Amy Bell - Study Coordinator
Participants are Type 2 Diabetes with Cardiovascular Disease
Contact: Amy Bell, (901) 448-1008; asbell@uthsc.edu

Recruitment is Closed

Diabetes Prevention Program Outcomes Study (DPPOS)
Samuel Dagogo-Jack, MD (PI); Faye Hampton, RN - Study Coordinator
Sponsor: NIH/NIDDK
Participants of all races who had Impaired Glucose Tolerance between the ages of 25 with no upper age limit with a BMI of >24
Location: 920 Madison Ave. Suite 300A, Memphis, TN 38163
Contact: Phone: (901) 448-5290; ehampto5@uthsc.edu

Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC)
Samuel Dagogo-Jack, MD (PI); Ibiye Owei, MBBS- Study Coordinator
Sponsor: NIH
Participants are healthy individuals with either one or both parents with type 2 diabetes, age group 18-65
Contact: Fataoumatta Ceesay (901) 448-5299; fceesay@uthsc.edu

Epidemiology of Diabetes Interventions and Complications Study (EDIC)
Sam Dagogo-Jack, MD, FRCP (PI); Christine S. Wigley R.N. - Study Coordinator
Sponsor: NIH
Division of Endocrinology, Diabetes, and Metabolism
Participants are type 1 diabetics from the Diabetes Control and Complications Trial (DCCT)
Location: 920 Madison Ave. Suite 300A, Memphis, TN 38163
Contact: (901) 448-7942 E-mail: cwigley@uthsc.edu

Pre-Diabetes Study

Last Published: Jun 22, 2017